| Juan Manuel Rodriguez, PSYD | |
|
759 S Van Ness Ave, San Francisco, CA 94110-1908 | |
| (415) 642-4550 | |
| Not Available |
| Full Name | Juan Manuel Rodriguez |
|---|---|
| Gender | Male |
| Speciality | Clinical Psychologist |
| Experience | 13 Years |
| Location | 759 S Van Ness Ave, San Francisco, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043406689 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City And County Of San Francisco | 1658280748 | 265 |
News Archive
Encap Drug Delivery and Lena Nanoceutics today announce a collaboration agreement to develop a new drug delivery technology (Nano-Capsules) which combines Lena's proprietary nano-particle engineering technology with Encap's liquid filled hard capsule technology.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.
Speaking at the UK National Stem Cell Network Annual Science Meeting in Edinburgh, Professor Silvia Marino shows how the mechanisms normally involved in balancing different functions of stem cells may also contribute to cancer.
Throughout the history of medicine and science, researchers have frequently discovered evidence of promising ways to improve health outcomes for patients and communities - only to have those findings languish in papers published in scientific journals.
› Verified 5 days ago
| Entity Name | City & County Of San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982737524 PECOS PAC ID: 1658280748 Enrollment ID: O20050309000770 |
News Archive
Encap Drug Delivery and Lena Nanoceutics today announce a collaboration agreement to develop a new drug delivery technology (Nano-Capsules) which combines Lena's proprietary nano-particle engineering technology with Encap's liquid filled hard capsule technology.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.
Speaking at the UK National Stem Cell Network Annual Science Meeting in Edinburgh, Professor Silvia Marino shows how the mechanisms normally involved in balancing different functions of stem cells may also contribute to cancer.
Throughout the history of medicine and science, researchers have frequently discovered evidence of promising ways to improve health outcomes for patients and communities - only to have those findings languish in papers published in scientific journals.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan Manuel Rodriguez, PSYD 759 S Van Ness Ave, San Francisco, CA 94110-1908 Ph: (415) 642-4528 | Juan Manuel Rodriguez, PSYD 759 S Van Ness Ave, San Francisco, CA 94110-1908 Ph: (415) 642-4550 |
News Archive
Encap Drug Delivery and Lena Nanoceutics today announce a collaboration agreement to develop a new drug delivery technology (Nano-Capsules) which combines Lena's proprietary nano-particle engineering technology with Encap's liquid filled hard capsule technology.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.
Speaking at the UK National Stem Cell Network Annual Science Meeting in Edinburgh, Professor Silvia Marino shows how the mechanisms normally involved in balancing different functions of stem cells may also contribute to cancer.
Throughout the history of medicine and science, researchers have frequently discovered evidence of promising ways to improve health outcomes for patients and communities - only to have those findings languish in papers published in scientific journals.
› Verified 5 days ago
B L. Elliott, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 747 Front St, San Francisco, CA 94111 Phone: 707-508-6341 | |
Dr. David Tim Lewis, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 703 Market St Ste 1208, San Francisco, CA 94103 Phone: 415-350-9611 | |
Candy Ho Katoa, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 401 Parnassus Ave, Lp 488, San Francisco, CA 94143 Phone: 415-476-7133 | |
Stephanie Lauren Post, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1630 Lombard St, San Francisco, CA 94123 Phone: 703-901-6833 | |
Anett Atman, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3600 California St, San Francisco, CA 94118 Phone: 415-820-9612 | |
Dr. Andrea Samuels, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1947 Divisadero St Ste 1d, San Francisco, CA 94115 Phone: 510-847-4858 | |
Timothy Kim, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1610 Scott St, San Francisco, CA 94115 Phone: 510-365-5066 |